MissionIR Articles

Targeted Medical Pharma, Inc. is a biotechnology company that develops and distributes prescription medical foods for chronic disease treatment, convenience kits, and generic pharmaceuticals to physicians and pharmacies in the United States and Middle East.…

PhotoMedex, Inc. is a skin health company that provides integrated disease management and aesthetic solutions to dermatologists, professional aestheticians, and consumers. The company offers products and services that address skin diseases and conditions, including psoriasis…

Regado Biosciences, Inc. is a biopharmaceutical company discovering and developing antithrombotic drug systems for acute and sub-acute cardiovascular and other indications. The company’s lead product includes REG1, an anticoagulant in clinical trials for use in…

Can-Fite BioPharma, Ltd. is a biotechnology company developing drugs for treating cancer and autoimmune inflammatory diseases. Principally, the company develops CF101, which is in Phase III study for the treatment of psoriasis and has completed…

Enzo Biochem, Inc. is an integrated life sciences and biotechnology company that focuses on diagnostic and research products. The company operates in three segments: the Clinical Labs segment offers clinical laboratory tests/procedures used in general…

Atossa Genetics, Inc. is a healthcare company developing and marketing cellular and molecular diagnostic risk assessment products for breast cancer. The company’s diagnostic tests include the ForeCYTE Breast Health Test, which provides personalized information about…

Trovagene Inc. (NASDAQ: TROV) develops diagnostic technologies for use in patient/disease screening and monitoring in various medical disciplines. The company’s urine-based testing platform helps to enhance cancer care management and women’s healthcare. The company’s technology…

Aastrom Biosciences, Inc. develops patient-specific cell products for treating severe, chronic ischemic cardiovascular diseases. The company is developing ixmyelocel-T, a multicellular therapy expanded from a patient’s own bone marrow and delivered directly to damaged tissues.…

Cancer Genetics, Inc. is an early-stage diagnostics company developing proprietary genomic tests and services to improve and personalize the diagnosis, prognosis, and response to the treatment of cancer. The company’s tests target many cancers, including…

Oxygen Biotherapeutics, Inc. is a development stage company developing biotechnology products that deliver oxygen to target tissues in the body. The company develops Oxycyte, an oxygen carrier for use in situations of acute ischemia, which…

Invivo Therapeutics Holdings Corp. (OTCBB: NVIV) is a development stage company engaged in the development and commercialization of biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.…

Amarin Corporation plc is a biopharmaceutical company engaged in developing and bringing to market therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and the therapeutic benefits of…

Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues for research and medical applications. The company’s 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the…

BioSpecifics Technologies Corp. (NASDAQ: BSTC) is a biopharmaceutical company that is focused on developing an injectable collagenase for various clinical indications. Under the XIAFLEX name, BioSpecifics provides injectable collagenase for the treatment of adult Dupuytren’s…

Venaxis, Inc. develops and commercializes products for unmet diagnostic and therapeutic needs. Its lead product candidate includes APPY1, a blood-based diagnostic test designed to aid in the evaluation of patients for acute appendicitis. The company,…

SciClone Pharmaceuticals, Inc. provides therapies for the treatment of oncology, infectious diseases, cardiovascular, urological, respiratory, and central nervous system disorders in China and internationally. Its principal product is ZADAXIN, which is used for the treatment…

Acorda Therapeutics, Inc. is a commercial-stage biopharmaceutical company that engages in identifying, developing and bringing to market therapies for multiple sclerosis (MS), spinal cord injury and other central nervous system disorders. Acorda’s products include: Ampyra (dalfampridine), a…